Hematology/Oncology · Hollywood, FL
NPI
1871577221
Since 2005
Specialty
Hematology/Oncology
Code 174400000X
Group practices
1
Medicare group memberships
Hospitals
4
Hospital affiliations
7770 Davie Road Ext
Hollywood, FL, 33024
Phone (954) 450-1808
Groups this clinician bills Medicare through
Medicare paid, 2024
$296K
18,084 services
Medicare patients, 2024
118
Average age 74
Drug cost, 2024
$4.8M
1,001 prescriptions
Company payments, 2025
$19K
From 46 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Isaac Levy was code 36415 (venipuncture blood collection), 260 times for 99 patients. In total Isaac Levy billed 18,084 services in 39 codes, and Medicare paid $296K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2019-10-11.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 260 | 99 | $8.65 | $2,249 |
| 85025 Blood Count | Office | 260 | 99 | $7.61 | $1,979 |
| 99215 Office E&M - Established | Office | 228 | 108 | $111.07 | $25K |
| 96365 Intravenous Infusion, Hydration | Office | 60 | 16 | $49.55 | $2,973 |
| 99205 Office E&M - New | Office | 40 | 40 | $156.40 | $6,256 |
By year: 2022 $577K for 36,917 services; 2023 $510K for 53,438 services; 2024 $296K for 18,084 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 260 | 99 | $8.65 | $2,249 |
| 85025 Blood Count | 260 | 99 | $7.61 | $1,979 |
Medicare prescription drug claims, 2024
In 2024, the drug Isaac Levy prescribed most often to Medicare patients was Letrozole, with 168 prescriptions and refills. In total Isaac Levy wrote 1,001 Medicare prescriptions that cost $4.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Letrozole Generic | 168 | 373 | 45 | $2,807 |
| Lenalidomide Generic | 64 | 64 | Under 11 | $769K |
| Hydroxyurea Generic | 59 | 106 | 17 | $1,561 |
| Dexamethasone Generic | 52 | 52 | 12 | $745 |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 40 | 40 | Under 11 | $711K |
| Imbruvica Ibrutinib | 37 | 37 | Under 11 | $574K |
| Brukinsa Zanubrutinib | 36 | 36 | Under 11 | $548K |
| Imatinib Mesylate Generic | 28 | 28 | Under 11 | $21K |
| Prednisone Generic | 27 | 29 | Under 11 | $78.97 |
| Eliquis Apixaban | 25 | 35 | Under 11 | $20K |
| Valacyclovir Valacyclovir Hcl | 25 | 43 | Under 11 | $1,071 |
| Darzalex Daratumumab | 24 | 24 | Under 11 | $115K |
| Anastrozole Generic | 23 | 49 | Under 11 | $184 |
| Methylprednisolone Sodium Succ Methylprednisolone Sod Succ | 21 | 21 | Under 11 | $261 |
| Abiraterone Acetate Generic | 21 | 21 | Under 11 | $118K |
Brand drugs: 340 claims; generic drugs: 661 claims; opioid claims: 15.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Isaac Levy $19K ($4,929 in general payments such as food, travel and fees and $14K for research) from 46 companies. The largest payer was Genzyme Corporation with $14K.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 9 | $14K |
| Novartis Pharmaceuticals Corporation NVS | 18 | $733 |
| Pfizer Inc. PFE | 22 | $521 |
| AstraZeneca Pharmaceuticals LP AZN | 19 | $461 |
| GlaxoSmithKline, LLC. GSK | 12 | $238 |
| Merck Sharp & Dohme LLC MRK | 10 | $213 |
| Abbvie Inc. ABBV | 4 | $183 |
| Janssen Biotech, Inc. JNJ | 10 | $167 |
| Sobi, Inc SOBI.ST | 3 | $138 |
| Alexion Pharmaceuticals, Inc. AZN | 5 | $132 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.